High-dose primaquine reduces vivax relapses: time for change.
Saved in:
| Title: | High-dose primaquine reduces vivax relapses: time for change. |
|---|---|
| Authors: | Commons RJ; Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin NT 0811, NT, Australia; WorldWide Antimalarial Resistance Network, Darwin, NT, Australia; General and Subspecialty Medicine, Grampians Health Ballarat, Ballarat, VIC, Australia. Electronic address: robert.commons@menzies.edu.au., Chu CS; Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Vientiane, Laos; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK. |
| Source: | The Lancet. Infectious diseases [Lancet Infect Dis] 2025 Aug; Vol. 25 (8), pp. 832-833. Date of Electronic Publication: 2025 Mar 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
